Literature DB >> 30235042

Effectiveness of Intraductal Meibomian Gland Probing in Addition to the Conventional Treatment in Patients with Obstructive Meibomian Gland Dysfunction.

Tuğba Kurumoglu Incekalan1, Ibrahim Inan Harbiyeli2, Meltem Yagmur2, Elif Erdem2.   

Abstract

Purpose: To evaluate the effectiveness of intraductal meibomian gland probing in addition to conventional treatment for the management of obstructive meibomian gland dysfunction (O-MGD).
Methods: Totally, 40 patients were divided into two groups to receive either conventional treatment alone (group 1: 40 eyes of 20 patients) or conventional treatment plus probing (group 2: 40 eyes of 20 patients). The ocular surface disease index score, Schirmer 1 test, tear film break-up time, Oxford grading of ocular surface, meibum expressibility, and quality scores were evaluated baseline and compared with the end of treatment (day 30 and day 90).
Results: There was no significant difference in baseline scores between groups (All p > 0.05). All scores demonstrated significantly improvement from baseline in both group, and it was faster in group 2 (All p < 0.05).
Conclusion: This study showed that intraductal meibomian gland probing seems to provide rapid symptom relief and clinical improvement for patients with O-MGD.

Entities:  

Keywords:  Conventional treatment; OSDI score; intraductal meibomian gland probing; obstructive meibomian gland dysfunction; rapid symptom relief

Mesh:

Substances:

Year:  2018        PMID: 30235042     DOI: 10.1080/09273948.2018.1522357

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  4 in total

Review 1.  Advances in dry eye disease treatment.

Authors:  Erin C O'Neil; Matthew Henderson; Mina Massaro-Giordano; Vatinee Y Bunya
Journal:  Curr Opin Ophthalmol       Date:  2019-05       Impact factor: 3.761

2.  Meibography guided intraductal meibomian gland probing using real-time infrared video feed.

Authors:  Steven L Maskin; Sreevardhan Alluri
Journal:  Br J Ophthalmol       Date:  2020-02-27       Impact factor: 4.638

Review 3.  Dry eye: why artificial tears are not always the answer.

Authors:  Minji Kim; Yonghoon Lee; Divy Mehra; Alfonso L Sabater; Anat Galor
Journal:  BMJ Open Ophthalmol       Date:  2021-04-08

Review 4.  Non-pharmaceutical treatment options for meibomian gland dysfunction.

Authors:  Reiko Arita; Shima Fukuoka
Journal:  Clin Exp Optom       Date:  2020-01-13       Impact factor: 2.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.